Mingchen Health Co.,Ltd. (SHE:002919)
China flag China · Delayed Price · Currency is CNY
17.43
+0.51 (3.01%)
Aug 25, 2026, 3:04 PM CST

Mingchen Health Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-20.2728.3146.7270.3625.39133.49
Depreciation & Amortization
30.8923.6547.28175.3250.3124.1
Other Amortization
17.2513.8710.1312.258.54.95
Loss (Gain) From Sale of Assets
0.730.51-4.38-2.07-0.10.01
Asset Writedown & Restructuring Costs
-38.98-33.7974.3544.59-1.5715.19
Loss (Gain) From Sale of Investments
-1.06-0.92-0.52-0.08-0.75-22.06
Other Operating Activities
2.721.30.61.920.961.71
Change in Accounts Receivable
-53.94-40.23-437.84-178.8319.1-75.14
Change in Inventory
9.561.37121.77-17.537.59-2.43
Change in Accounts Payable
149.6172.7336.14-19.17-2.097.43
Change in Other Net Operating Assets
0----20.78-
Operating Cash Flow
125.0887.65165.2869.3173.2579.87
Operating Cash Flow Growth
-5.19%-46.97%138.44%-5.38%-8.28%-53.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-60.92-86.51-48.62-12.7-150.54-15.47
Sale of Property, Plant & Equipment
00.010.660.5400.05
Cash Acquisitions
----8.58-
Divestitures
-----25.14
Investment in Securities
-63.8546.1-57.86-11.95103.26
Other Investing Activities
26.31.240.160.080.75-63.35
Investing Cash Flow
-98.47-39.16-105.66-12.08-129.2549.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-80----
Total Debt Issued
5080----
Short-Term Debt Repaid
------39
Long-Term Debt Repaid
--15.13-24.2-26.88-24.2-6.02
Total Debt Repaid
-45.13-15.13-24.2-26.88-24.2-45.02
Net Debt Issued (Repaid)
4.8764.87-24.2-26.88-24.2-45.02
Repurchase of Common Stock
-31-31----
Common Dividends Paid
-14.82-13.78-33.27--36.64-32.29
Other Financing Activities
21.46-0----
Financing Cash Flow
-19.4920.09-57.46-26.88-60.84-77.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-1.41-0.270.320.21.87-
Net Cash Flow
5.768.312.4730.55-114.9752.19

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
64.161.14116.6656.61-77.2864.4
Free Cash Flow Growth
40.33%-99.02%106.08%---58.99%
Free Cash Flow Margin
3.78%0.07%8.45%3.46%-8.18%8.65%
Free Cash Flow Per Share
0.240.000.440.21-0.280.24
Levered Free Cash Flow
56.59100.43110.2425.2630.7323.14
Unlevered Free Cash Flow
57.72101.56111.2327.5631.9424.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
45.647.6644.9939.6345.849.99
Change in Working Capital
133.854.73-8.9-232.99-9.49-77.52